Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
AstraZeneca
Boehringer Ingelheim
Colorcon
Mallinckrodt

Last Updated: January 25, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Levonordefrin


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Levonordefrin?

Levonordefrin is an investigational drug.

There have been 5 clinical trials for Levonordefrin. The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2021.

The most common disease conditions in clinical trials are Pulpitis, Trismus, and Hypesthesia. The leading clinical trial sponsors are Cairo University, Novalar Pharmaceuticals, Inc., and University of Sao Paulo.

There are two hundred and forty-seven US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for Levonordefrin
TitleSponsorPhase
Anesthetic Efficacy of %4Alexadricaine Versus %2 Mepicaine-L in ChildrenCairo UniversityPhase 3
Survival Rate After TheraCal PT Pulpotomy Versus MTA Pulpotomy in Children With Vital Primary Molars.Cairo UniversityN/A
Effect of Magnesium Sulphate Added to Mepivacaine Hydrochloride on Inferior Alveolar Nerve Block Success in Patients With Symptomatic Irreversible Pulpitis in Mandibular Molars: A Randomized Clinical Trial.Cairo UniversityN/A

See all Levonordefrin clinical trials

Clinical Trial Summary for Levonordefrin

Top disease conditions for Levonordefrin
Top clinical trial sponsors for Levonordefrin

See all Levonordefrin clinical trials

US Patents for Levonordefrin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Levonordefrin ⤷  Try it Free Methods and compositions for treating infection UNIVERSITY OF ROCHESTER (Rochester, NY) UNIVERSITY OF KANSAS (Lawrence, KS) ⤷  Try it Free
Levonordefrin ⤷  Try it Free Treatment of sexual dysfunction Rejoy (Irvine, CA) ⤷  Try it Free
Levonordefrin ⤷  Try it Free Surface-independent, surface-modifying, multifunctional coatings and applications thereof NORTHWESTERN UNIVERSITY (Evanston, IL) ⤷  Try it Free
Levonordefrin ⤷  Try it Free Small molecule agonists of neurotensin receptor 1 SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE (La Jolla, CA) ⤷  Try it Free
Levonordefrin ⤷  Try it Free Cross-linked collagen comprising metallic anticancer agents MiMedx Group, Inc. (Marietta, GA) ⤷  Try it Free
Levonordefrin ⤷  Try it Free Theranostics platform and methods of use Sanford Burnham Prebys Medical Discovery (La Jolla, CA) ⤷  Try it Free
Levonordefrin ⤷  Try it Free Graft including osseous tissue and cartilage tissue for augmentation rhinoplasty, and method of performing augmentation rhinoplasty using the graft ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Levonordefrin

Drugname Country Document Number Estimated Expiration Related US Patent
Levonordefrin World Intellectual Property Organization (WIPO) WO2014052836 2032-09-27 ⤷  Try it Free
Levonordefrin European Patent Office EP3307280 2035-06-11 ⤷  Try it Free
Levonordefrin World Intellectual Property Organization (WIPO) WO2016201286 2035-06-11 ⤷  Try it Free
Levonordefrin Australia AU2005250314 2024-02-27 ⤷  Try it Free
Levonordefrin Australia AU2005306618 2024-02-27 ⤷  Try it Free
Levonordefrin Canada CA2557330 2024-02-27 ⤷  Try it Free
Levonordefrin Canada CA2587361 2024-02-27 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
AstraZeneca
Boehringer Ingelheim
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.